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ABSTRACT
Rhinosinusitis is mostly affected by viral infections and allergy and resolves without antibiotics usage. However, 
antibiotics are still frequently used as drug of choice for rhinosinusitis. If conservative treatments failed, surgical 
procedures had to be done. Neurogenic inflammation is involved in rhinosinusitis. Possibly because rhinosinusitis-
induced chronic gingivitis successfully relieved by the “assisted drainage therapy” (ADT). This new periodontal 
therapy consists of scaling and root planing followed by subgingival massage. However, the mechanism had not 
been clearly verified. Objective: To verify the mechanism of allergic rhinosinusitis symptoms relief by ADT. 
Methods: Randomized control time series design experimental study was conducted in two groups of Wistar rats. 
Allergic sensitization was performed by injections and inhalation of ovalbumin (OVA). Gingivitis was induced by 
synthetic Porphyromonas gingivalis lipopolysaccharide (PgLPS1435/1450). One group was subjected to ADT before 
inhalation and another groups without ADT. Immunohistochemistry for biomarkers of allergic reaction (LTC4 
and ECP) and neurogenic inflammation (CGRP and VIP) performed. Results: After OVA inhalation, allergic 
reaction and neurogenic inflammation biomarkers had significantly lower in rats subjected to ADT before inhalation 
than without ADT (p=0.001). Conclusion: ADT significantly decreased nasal allergic reaction and neurogenic 
inflammation biomarkers, therefore could be proposed as an adjunct therapy of allergic rhinosinusitis.
ABSTRAK 
Mekanisme berkurangnya gejala rinosinusitis alergi setelah terapi assisted drainage. Rinosinusitis terutama 
disebabkan oleh virus dan alergi, serta akan sembuh dengan sendirinya tanpa antibiotik. Akan tetapi, antibiotik 
masih sering dipakai sebagai obat pilihan untuk rinosinusitis. Bila terapi konservatif gagal maka perlu dilakukan 
tindakan bedah. Selain alergi, keradangan neurogenik juga terlibat dalam rinosinusitis. Beberapa laporan kasus 
menduga bahwa gingivitis kronis memicu rinosinusitis dan suatu terapi yang disebut sebagai assisted drainage 
(ADT) dapat mengurangi gejala dalam hitungan menit. Terapi periodontal temuan baru tersebut merupakan 
pembersihan karang gigi yang disertai dengan pemijatan subgingiva, namun demikian mekanismenya masih perlu 
diverifikasi. Tujuan: Untuk melakukan verifikasi mekanisme kerja ADT dalam mengurangi gejala rinosinusitis 
dengan cepat. Metode: Studi eksperimental randomized control time series design dilakukan pada dua kelompok 
tikus Wistar. Sensitisasi alergi dilakukan dengan injeksi dan inhalasi ovalbumin (OVA). Gingvitis diinduksi 
dengan lipopolisakarida Porphyromonas gingivalis (PgLPS1435/1450) sintetis. Pada satu kelompok dilakukan ADT 
sebelum inhalasi dan kelompok lain tanpa ADT. Pemeriksaan jaringan hidung dilakukan dengan pemeriksaan 
imunohistokimia pada biomarker reaksi alergi (LTC4 dan ECP) serta keradangan neurogenik (CGRP dan VIP). 
Analisa data menggunakan ANOVA. Hasil: Beberapa menit setelah inhalasi OVA, ekspresi biomarker reaksi alergi 
dan keradangan neurogenik lebih rendah secara signifikan (p=0,001) pada tikus yang mendapat perlakuan ADT 
sebelum inhalasi dibandingkan tanpa inhalasi. Simpulan: ADT mampu secara signifikan mengurangi biomarker 
reaksi alergi dan keradangan neurogenik dalam hitungan menit, sehingga dapat diusulkan sebagai terapi ajuvan 
rinosinusitis alergi.
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INTRODUCTION
Rhinosinusitis could be acute or chronic. Symptom 
that persisted for more than 12 weeks is categorized as 
chronic rhinosinusitis (CRS).1 It is a disease presented 
by chronic symptoms such as nasal obstruction, 
rhinorrhea, hyposmia and facial pain, highly prevalent 
and has a considerable impact on quality of life.2 
Chronic rhinosinusitis affects approximately 30 million 
Americans and results in an estimated 11.6 million 
physician visits and $4.3 billion in health care costs 
annually. CRS mostly related to viral infections and 
allergy, and self limited without the use of antibiotics. 
However, in the USA there were 13 million antibiotics 
prescription for rhinosinusitis.3
Pathophysiology of CRS has not been established, allergic 
reaction as well as neurogenic involvement have been 
hypothesized. Many factors may involved in its allergic 
involvement, such as IgE, leukotriene and eusinophils. 
The IgE activates mastcells or basophils via cross-
linking of the IgE receptors.9 Leukotriene, an important 
mediator involved in allergy, is a product released by mast 
cells and basophils degranulation after stimulation by 
lippopolysaccharide produced by bacteria.9 It increases 
airway hyperrensponsiveness as well as mucous secretion, 
especially leukotriene C4 (LTC4). The presence of 
eosinophils in rhinosinusitis is owing to its ability to 
infiltrate the sinus mucosa. Its activation can be detected 
with eosinophilic cationic protein (ECP) release.10 
Based on the neurogenic switching hypothesis, sensory 
and parasympathetic nerves activation play a role in the 
interaction of immunogenic and neurogenic inflammation. 
This might be involved in the pathophysiology of CRS and 
accounted for nasal symptoms.4,11 The maxillary sensory 
nerve involves in CRS by secretion of neuropeptide 
calcitonin gene-related peptide (CGRP) that causes 
sneezing as well as increases secretion. The vasoactive 
intestinal peptide (VIP) from parasympathetic nerve 
increases secretion as well as vasodilatation.12,13 
Conservative treatments of CRS are decongestants, 
corticosteroids, antibiotics and diathermy. Un-fortunately, 
if failed, surgical procedures such as adenoidectomy 
had to be done.2 Interestingly, in accordance with the 
traditional theory of CRS etiology, recent studies suggest 
a positive bacterial culture is found in only about 0.5% 
to 2% of viral RS cases, thus the paradigm is changing; 
causes other than viral infection i.e. allergy, or other 
causes must be found.3 Therefore, it is not surprising that 
despite its widespread prevalence, the pathophysiology 
has not fully understood until recently, and no optimal 
treatment has been identified.1 
Whilst until now medical community is still uncertain 
in CRS pathophysiology, “good news” emerged from 
dental literatures which suggested that CRS may also 
connected to dental infection. It was reported that CRS 
in children could be caused by chronic gingivitis. In 
previous case reports, the assisted drainage therapy 
(ADT) was able to relief clinical symptoms of severe 
CRS i.e. nasal congestion and headache in minutes.4,5
The assisted drainage therapy (ADT) was named after 
a periodontal treatment, which developed by Utomo 
and proposed as a new invention in periodontology and 
medicine, especially in asthma management. 4-6 It con-
sists of scaling and root planning (SRP) accompanied 
by gingival sulcus massage. Human study confirming 
the rapid effect of ADT in relieving of CRS symptoms 
had not been done; nevertheless, a study of rapid relief 
of ashmatic symptoms, a comorbidity of rhinosinusitis, 
in allergic children had been conducted in 2007.6 The 
concept of one airway one disease and axon reflex in 
asthma and rhinosinusitis pathophysiology may eluci-
date its similar results.7,8
Therefore, the objective of this study was to verify 
the mechanism how ADT rapidly relief allergic CRS 
symptoms by measuring the allergic reaction (LTC4 
and ECP) and neurogenic inf lammation (VIP and 
CGRP) biomarkers in allergic Wistar rats. Finding of 
these markers might increase our knowledge on the 
pathophysiology of CRS.
METHODS
In this study, Wistar rats were initially allergic-induced 
with ovalbumin (OVA), then to create chronic gingivitis 
model, upper gingiva was injected with synthetic 
Porphyromonas gingivalis lipo-polysaccharide with 
mass ion 1435 and 1450 (PgLPS1435/1450).
14 The assisted 
drainage therapy was done to certain groups to verify 
its effect towards the rapid relief of CRS symptoms, 
based on the modulation of allergic reaction (LTC4 
and ECP), as well as neurogenic inflammation (VIP 
and CGRP) biomarkers. Laboratory examination for 
gingiva and nasal tissues was done with peroxidase 
im-munohistochemistry. Statistical analysis was done 
with analysis of variance (ANOVA) using SPSS 15.
 
Male Wistar rats (120-150gr) were randomly selected 
into two experimental groups: (A)without the assisted 
drainage therapy, (B)with the assisted drainage therapy 
and one control group. Each group was divided into 3 
subgroups (A1-3 and B1-3) which each consisted of 6 
rats. Subgroups 1, 2 and 3 were allergic rats with intra 
sulcus (i.s.) injection of PgLPS1435/1450 received one of 
three doses 0.3, 1.0 and 3.0μg/mL respectively. These 3 
doses represented low (0.3μg/mL), cut off point (1.0μg/
mL) and high (3.0μg/mL).15 Control group was injected 
with phosphate buffered saline (PBS) intraperitoneally 
(i.p.). The chronologic of randomized control series 
design research was shown in Figure 1. 
Allergic sensitization and inhalation in rats was done 
according to Toward and Broadley’s method.16 In day 1 
and 14 Wistar rats were injected i.p. with OVA (Sigma 
Aldrich, Germany), 10µg in 10mg AIOH3 diluted until 
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1mL volume, each dose was 200µL. In day 21, they 
were subjected to OVA inhalation, 1mg/mL in sterile 
saline 1mL dose using nebulizer (OMRON™, USA) 
for 30 minutes. Intra sulcus (i.s) injections to induce 
gingivitis as well as to modulate allergic reaction with 
0.3, 1.0 and 3.0μg/mL PgLPS1435/1450 (Astarte Biol, USA) 
were done in day 11 and 12 according to Dumitrescu’s 
method in upper right molar (Figure 2), 4 days after 
stimulation resulted in chronic gingivitis (verified 
based on the change of gingival histopathological 
sample).17 Control group were injected with PBS i.p.
The assisted drainage therapy, using sickle shaped 
scaler (Figure 3 and  4) was done for 3 minutes between 
the upper first and second molars (Figure 2) 20 minutes 
before OVA inhalation. After OVA inhalation, rats were 
sacrificed 30-40 minutes later. Each step (control, day 14, 
day 21 etc.), tissue samples were taken by dissecting the 
nasomaxillary  tissue above the injected area (Figure 2), 
thus every subgroup must consist 18 rats. Sacrifice was 
done according to the euthanasia protocol. The local and 
systemic effect of ADT towards gingiva and nasal tissue 
were examined with peroxidase immunohistochemistry 
using diamino-benzidine (DAB). 
This research and its laboratory examinations were 
conducted in the Biology Department Brawijaya 
University Malang, October 2008 until February 2009. 
The research protocol had been approved by the Animal 
Care and Use Ethical Committee, Faculty of Veterinary 
Medicine Airlangga University, Surabaya. Statistical 
analysis was done with Analysis of Variance (ANOVA) 
to reveal the interaction between variable doses of 
OVA, PgLPS1435/1450 and the assisted drainage therapy. 
Figure 2. Location of injection and the Assisted Drainage 
Therapy (ADT) in Wistar rats
Figure 3. Assisted drainage therapy, scaling root planing 
with gingival sulcus massage (arrow) (adapted from Newman 
et al, 2006)19
Figure 4. The assisted drainage therapy in rat
Figure 5. Nasal CGRP expression. After PgLPS1435/1450 i.s 2nd 
injection before OVA i.p. injection (day 14). 400x
Figure 1. Randomized control series study design of 
OVA-induced allergic rats and allergic rats induced with 
PgLPS1435/1450
Notes:
O1 rats which will be allergic induced with ovalbumin 1
st i.p. 
injection in day 1
O2 allergic rats will be induced with PgLPS1435/1450 i.s. injection 
in day 11 and 12 to create chronic gingivitis as well as 
ovalbumin 2nd i.p. injection in day 14
O3 allergic rats with chronic gingivitis which will be treated 
with the assisted drainage therapy before olbumin inhalation 
in day 21
O4 rats with allergy and chronic gingivitis that had been 
induced with OVA inhalation, without or with the assisted 
drainage therapy
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RESULTS
Immunohistochemical examination 
Allergic reaction and neurogenic inf lammation 
biomarkers expressions of gingiva and nasal 
immunohistochemistry samples were counted per 
view with light microscope (Olympus™ CX-31). The 
image of CGRP expressions in nasal tissue was shown 
in Figure 5. 
Effect of PgLPS 1435/1450 injection towards allergic rats
After intraperitoneal ovalbumin allergic sensitization 
and intrasulcular injection of PgLPS1435/1450 0.3, 1.0 
and 3.0 µg/mL, in day 11 and 12, there were several 
modulation of allergic and neurogenic inflammation 
biomarkers of nasal tissue in day 14 and 21. Nasal tissue 
examination results and statistical significance were 
shown in Table 1 and Table 2. 
Local and systemic effects of ADT on day 21 using 
OVA inhalation 
In order to verify the ability of ADT to create systemic 
effect; hence, from gingival stimulation which resulted 
in decrease of nasal symptoms, gingival and nasal 
tissue examinations should be evaluated. The local 
effect of ADT towards gingival tissue in allergic rats, 
which were subjected to OVA inhalation without ADT, 
revealed that they had significant higher expressions 
(p=0.001) of all allergic reaction (LTC4 and ECP) and 
neurogenic inflammation (VIP, CGRP) biomarkers 
if compared with group received ADT. Nasal tissue 
examination results and statistical significance were 
shown in Table 3. In this study, “rapid effect” would be 
verified, therefore euthanasia should be done as soon as 
possible, in this study it had been done approximately 
60 minutes after ADT. 
Effects of OVA, LPS and ADT in nasal tissue 
Viewing the modulation of biomarkers compared to 
control which caused by treatments of OVA, PgLPS 
1435/1450 and ADT in nasal tissue was easily evaluated. 
Control and the results in rats’ nasal tissue examinations 
with 3.0µg/mL PgLPS1435/1450 intra-sulcular injection 
could be seen in Figure 6a-d.
DISCUSSION
Several mechanisms have been proposed related to the 
inter relationship between CRS, migraine headache 
and allergy that are: (1) autonomic symptoms caused 
by parasympathetic cranial activation; (2) the neuro-
genic switching mechanism which were confirmed by 
other study.11,13 The auto-nomic nervous system role 
is important in CRS since it provides the general in-
nervation to the nose, with the parasympathetic nerves 
supplying the resting tone and controlling secretion; the 
sphenopalatine ganglion was account for this action.12,13
It was interesting that even in difficult allergic CRS, 
a child patient who was actually scheduled for nasal 
surgery, ADT rapidly relief her symptoms in minutes. 
Successful treatment result was confirmed by an ENT 
specialist one week later. It was true that according 
to the neurogenic switching mechanism, the trigger 
of sensory and parasympathetic stimulation could be 
initiated from chronic gingivitis.4,19
This study confirmed that the induction of chronic 
gingivitis by synthetic PgLPS1435/1450 is via toll-like 
receptor-2 (TLR2) and TLR4.14PgLPS only stimu-lates 
TLR4, not TLR2, which is dependable for the induction 
of the allergy related T-helper2 (Th2) cytokines.20 This 
study confirmed that PgLPS1435/1450 increased allergic 
reaction and neurogenic inflammation in nasal tissue, 
although the difference was not significant (Table 1).
In day 14, significant increase of inflammation bio-
markers were observed in all groups (Table 1). It was 
logical since higher LPS dose induced greater inflam-
matory response. This result was in line with other 
study which reported the increase of leukotriens from 
mast cells after PgLPS injection.9 
Table 1. Allergic reaction and neurogenic inflammation in allergic rats (nasal tissue, day 14)
Dependent 
variable
Allergic Only
Mean ± SD
Allergic Rats with PgLPS1435/1450 injection
Mean±SD
Allergic reaction 0.3µg/mL
n = 6
p 1.0µg/mL
n = 6
p 3.0µg/mL
n = 6
p
LTC4
ECP
Neurogenic 
inflammation
VIP
CGRP
2.167±1.722
3.000±0.894
  2.833±1.169
2.167±0.753
2.833±0.983
7.167±0.983
5.833±2.787
9.50±4.722
0.951
0.089
*0.142
 0.002
5.000±1.265
5.167±3.061
7.50±0.548
6.833±2.137
*0.140
 0.577
0.010
0.070
7.833±3.189
7.667±4.082
9.50±2.881
7.50±2.074
*0.001
 0.048
*0.001
*0.032
*significant (p<0.05)
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Table 2. Allergic reaction and neurogenic inflammation in allergic rats (nasal tissue, day 21)
Dependent 
variable
Allergic Only
Mean ± SD
Allergic Rats with PgLPS 1435/1450 injection
Mean±SD
Allergic reaction 0.3µg/mL
n = 6
p 1.0µg/mL
n = 6
p 3.0µg/mL
n = 6
p
LTC4
ECP
Neurogenic 
inflammation
VIP
CGRP
17.50±3.507
19.00±2.280
15.00±0.894
14.667±1.633
7.167±0.753
10.50±1.871
12.167±1.472
12.167±1.472
 *0.001
 *0.001
  0.218
  0.193
  9.833±5.879 
10.833±3.869
10.333±1.751
11.667±1.033
*0.014
*0.001
*0.016
 0.090
7.167±2.137
11.667±0.817
13.333±3.724
15.167±2.927
*0.001
*0.001
 0.649
 0.976
*significant (p<0.05)
Table 3. Allergic rats OVA inhalation with ADT vs without ADT (nasal tissue, PgLPS1435/1450 3.0µg/mL)
Dependent 
variable
Allergic
Pre-inhalation
Allergic OVA Inhalation
without ADT
Allergic OVA Inhalation
with ADT
without 
ADT vs. 
with ADT
Allergic reaction Mean ± SD Mean ± SD p Mean±SD p p
LTC4
ECP
Neurogenic 
inflammation
VIP
CGRP
7.167±2.137
11.667±0.817
13.333±3.724
15.167±2.927
22.00±1.414
17.833±0.753
19.333±2.160
18.167±4.119
*0.001
*0.001
*0.009
 0.177
    11.833±1.472
  17.00±3.033
6.00±3.225
3.167±1.941
*0.001
*0.003
*0.004
*0.001
*0.001
*0.001
*0.001
*0.001
*significant (p<0.05)
Figure 6A. Expression of LTC4 in allergic only and allergy 
with PgLPS11435/1450 3.0μg/mL injection
Figure 6B. Expression of ECP in allergic only and allergy 
with PgLPS1435/1450 3.0μg/mL injection
Figure 6C. Expression of CGRP in allergic only and allergy 
with PgLPS1435/1450 3.0μg/mL injection
Figure 6D. Expression of VIP in allergic only and allergy 
with PgLPS1435/1450 3.0μg/mL injection
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The effects of OVA, LPS (3.0µg/mL) and ADT in nasal 
tissue in Boxplots. Notes: (1) Control (pre-treatment); 
(2) before OVA 2nd i.p. injection (day 14): (3) after 
PgLPS1435/1450 2
nd i.s. injection, before 2nd OVA i.p. 
injection (day 14); (4) OVA pre-inhalation (day 21); (5) 
OVA inhalation without ADT; (6) OVA inhalation with 
ADT (arrow). The four boxplots showed that OVA i.p. 
injection, OVA inhalation and PgLPS1435/1450 i.s. injection 
were able to increase allergic reaction and the neurogenic 
inflammation biomarkers in the nasal tissue. On the 
opposite, ADT decreased allergic reaction and the 
neurogenic switching mechanism (Figure 6).
Interestingly, in day 21, opposite results were shown. 
The PgLPS injection have decreased all biomarkers 
that caused by OVA sensitization (Table 2). This result 
might mimics the endotoxin tolerance phenomenon, 
that resulted from the resistance of host immune 
response towards prolonged LPS stimulation.21 It was 
hypothesized that endotoxin tolerance resulted in the 
diminished interleukin (IL)-12p40 production and 
increased of IL-10 has led to the shifting to the allergy-
related immune response marked by expression of 
Th2.21 The result of our study supported the endotoxin 
tolerance theory and prolonged PgLPS in term of oral 
infection, increased allergic reaction making  higher 
role of the Th2 immune response.
Table 1 and 2 showed the results of allergic sensitization 
with OVA i.p. injection in Wistar rats with and without 
PgLPS1435/1450 i.s. injection in nasal tissue. At day 14, all 
rats received PgLPS1435/1450 injections had higher expres-
sions of all biomarkers compared with allergic group 
only. On the contrary, in day 21 all biomarkers had 
lower expressions in all doses compared with allergic 
group only, although it was not always significant.
Immunogenic and neurogenic inflammations in oral 
tissue could be triggered by LPS via TLRs, it was 
confirmed in this study that after PgLPS1435/1450 i.s. 
injection, gingival biomarkers expressions for allergic 
reaction and neurogenic inf lammation increases 
significantly (p=0.001). In neurogenic inflammation, 
continued release of VIP and CGRP is able to activate 
mast cells and basophils to release histamine and 
tryptase, that in turn stimulatesnerve endings, so 
called the neurogenic switching mechanism.11,19 In this 
study, it was also verified that PgLPS1435/1450 gingival 
i.s. injection was able to stimulate distant nerve tissue 
based on the increase of VIP and CGRP expressions 
in the nasal tissue. In this study, the verification of 
mast cells and basophils activations in this study 
was indicated by the increase of LTC4 expressionand 
eosinophils activation by ECP expression (Table 1).
The result of this study was inconsistent with previous 
study in neonate Balb/c mice, which reported that only 
low dose (<1.0µg/mL) of PgLPS increased allergy via 
serum IgE examination after 2 months.15 Since this 
study was conducted only 21 days and in older rats, the 
result could be different. Nevertheless, it supported our 
hypothesis that all oral infections should be eliminated 
to reduce allergy.
Instant resolution of rhinosinusitis symptoms after the 
ADT was suspected due to rapid decrease of the allergic 
and neurogenic inflammation in allergic Wistar rats in 
this study. The most important systemic effect of ADT 
in allergic rhinosinusitis was its ability to improve 
sinusitis symptoms verified by significant decrease 
(p=0.001) of LTC4, ECP, VIP and CGRP expressions 
in nasal tissue within minutes after OVA inhalation 
(Table 3 and Figure 6a-d). This phenomenon could be 
explained by the occurrence of ”synaptic plasticity” 
(change in response strength of transmission over 
synaptic pathways) during ADT which able to slow 
down the nerve transmission.22 
Table 3 showed that in nasal tissue of allergic rats that 
were subjected to OVA inhalation without ADT, had 
significant higher expression of all allergic reaction and 
neurogenic inflammation biomarkers compared with 
OVA inhalation with ADT. The local effect of ADT 
towards gingival tissue in allergic rats which were 
subjected to OVA inhalation without ADT revealed 
that they had significant higher expressions (p=0.001) 
of all allergic reaction (LTC4 and ECP) and neurogenic 
inflammation (VIP and CGRP) biomarkers compared 
with ADT. The systemic effect of ADT towards nasal 
tissue was shown in Table 3. The assisted drainage 
therapy by massaging the gingival sulcus for about 3 
minutes is suggested to increase local tissue temperature.
One study revealed that increase of tissue temperature 
will decrease tissue pH and increase of extracellular 
Ca2+ level.22 Disturbance of Ca2+ regulation which is 
important for pre-synapse stimulation resulted in the 
occurrence of ”synaptic plasticity” for several minutes 
which then lowering the synapse impulse flow.23 This 
condition resulted in an immediate “cut off” of the 
neurogenic switching mechanism after ADT verified 
by the rapid significant decrease of VIP (p=0.001), 
and CGRP (p=0.001) expressions in the gingival 
tissue (data not shown) and nasal tissue (Table 3). It 
also answered the main question: ”Why the assisted 
drainage therapy was able to improve nasal congestion 
within minutes?” 
Other solution for answering the question was 
considering the half-life of a substance. The half -life 
of allergic reaction biomarkers LTC4 was 7 minutes 
and ECP was 65 minutes.9,24 Since the time lag between 
ADT and rat euthanasia was approximately 60 minutes, 
it was logical that significant difference had already 
occurred.
The half-life for neurogenic switching mediators were 
very fast (VIP = 2-5mins and CGRP = 6-10mins).19 
Therefore, it was logical that ADT was able to cut 
off the neurogenic switching mechanism, either by 
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increasing the local tissue temperature or drainage of 
inflammatory mediators that came out concomitantly 
within the oozed blood after ADT had been done. 
Since nasal cavity also innervated by the maxillary 
nerve (CNV2); stimulation of this nerve can reflexively 
influence nasal engorgement, respiration rate, nasal 
secretion, and sneezing. Since most trigeminal 
stimulants were lipid soluble, such as volatile chemicals; 
the stimulations were possible.12 It was suggested that 
stimulated CNV2 and the SPG may caused multiple 
chemical sensitivity syndrome (MCS) that was 
sensitive to humidity, cold weather and volatile which 
were not related to allergy.12 It is in line with a study 
that showed “allergic” rhinosinusitis symptoms are 
not related to the increase of IgE, since IgE-mediated 
allergy is present only in a proportion of rhinosinusitis 
patients.25 Therefore, despite the presence of classical 
IgE-mediated allergy, based on elevated allergen-
specific serum IgE levels and positive skin prick tests, 
currently there is no direct evidence for allergy as a 
major cause of sinonasal inflammation in CRS. 
Consequently, other than allergy only, the role of oral 
infection was important in rhinosinusitis. Sensitiza-
tion of the CNV2 in the oral cavity which also inner-
vated nasal tissue was confirmed by the increase of 
CGRP expressions in gingival and nasal tissue after 
PgLPS1435/1450 injection. Stimulation of CNV2 in the 
gingiva may propagate antidromically (opposite to the 
direction of regular impulse) to the nasal cavity and 
able to stimulate parasympathetic nerve directly via 
the SPG.12,26 This action was verified by the increase 
of VIP expression in nasal tissue which was the main 
secretion of parasympathetic nerve, and also mimick-
ing the “axon reflex” mechanism in CRS and asthma 
connection.8,13 The connectivity of stimulation between 
nasal sensory and parasympathetic nerves also con-
firmed by other study.27
CONCLUSION 
Based on the significant decrease of allergic and neu-
rogenic biomarkers of CRS within minutes after the 
“assisted drainage” therapy, it was concluded that this 
therapy was an effective procedure for rapid relief of 
CRS which were suspected to be induced by periodontal 
infection. Additionally, this study also explained: (1) the 
unknown pathophysiology of CRS which may cause by 
the sensitization of SPG which initiated from chronic 
gingivitis of maxillary teeth and (2) that oral periodon-
topathic bacteria product, the P. gingivalis LPS, was able 
to increase allergic reaction, therefore elimination of oral 
infection was important to reduce allergy. Consequently, 
in order to minimize unnecessary as well as prolonged 
treatments and medications for the CRS, the collabora-
tion of medical practitioners, especially otolaryngologist 
and dental practitioners is important.
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